Summit Therapeutics

Summit Therapeutics EBIT Margin

The EBIT Margin (Operating Margin) of Summit Therapeutics (SMMT) as of Nov 22, 2026 is -8,960.56 %. In the previous year, EBIT Margin (Operating Margin) was -4,761.88 % — a change of 88.17% (lower).

EBIT Margin

-8,960.56 %

YoY

88.17%

Last updated:

EBIT Margin (Operating Margin) of Summit Therapeutics is 2022 -8,960.56 % . EBIT Margin (Operating Margin) of Summit Therapeutics was 2021 -4,761.88 % . It decreases by 88.17% lower compared to the previous year.

Summit Therapeutics's operating (EBIT) margin stands at -8,960.6%, down from 19.8% several years earlier.

The Summit Therapeutics EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2012
-1.98 USD
Jan 1, 2016
-1,057.39 USD
Jan 1, 2017
-173.11 USD
Jan 1, 2018
19.78 USD
Jan 1, 2019
-3,712.16 USD
Jan 1, 2020
-6,084.88 USD
Jan 1, 2021
-4,761.88 USD
Jan 1, 2022
-8,960.56 USD
The Summit Therapeutics EBIT Margin history
YEAREBIT MarginYoY
-8,960.56 %+88.17%
-4,761.88 %-21.74%
-6,084.88 %+63.92%
-3,712.16 %-18,871.24%
19.78 %-111.42%
-173.11 %-83.63%
-1,057.39 %+53,360.29%
-1.98 %+16.70%
-1.69 %-65.47%
-4.91 %-86.62%
-36.68 %-34.98%
-56.42 %+1,352.47%
-3.88 %-8.65%
-4.25 %+25.21%
-3.40 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Summit Therapeutics Stock analysis

What does Summit Therapeutics do? Summit Therapeutics Inc. is a global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines for the treatment of life-threatening and rare diseases. The company is headquartered in Massachusetts, USA and also has offices in Oxford, UK. Summit Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Summit Therapeutics stock

EBIT Margin (Operating Margin) of Summit Therapeutics is -8,960.56 % in 2022.

EBIT Margin (Operating Margin) of Summit Therapeutics changed from -4,761.88 % to -8,960.56 %, representing a 88.17% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Summit Therapeutics since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Summit Therapeutics with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Summit Therapeutics

All Key Metrics — Summit Therapeutics